It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ferroptosis is a regulated cell death due to the iron-dependent accumulation of lipid peroxide. Ferroptosis is known to constitute the pathology of ischemic diseases, neurodegenerative diseases, and steatohepatitis and also works as a suppressing mechanism against cancer. However, how ferroptotic cells affect surrounding cells remains elusive. We herein report the transfer phenomenon of lipid peroxidation and cell death from ferroptotic cells to nearby cells that are not exposed to ferroptotic inducers (FINs). While primary mouse embryonic fibroblasts (MEFs) and NIH3T3 cells contained senescence-associated β-galactosidase (SA-β-gal)-positive cells, they were decreased upon induction of ferroptosis with FINs. The SA-β-gal decrease was inhibited by ferroptotic inhibitors and knockdown of Atg7, pointing to the involvement of lipid peroxidation and activated autophagosome formation during ferroptosis. A transfer of cell culture medium of cells treated with FINs, type 1 or 2, caused the reduction in SA-β-gal-positive cells in recipient cells that had not been exposed to FINs. Real-time imaging of Kusabira Orange-marked reporter MEFs cocultured with ferroptotic cells showed the generation of lipid peroxide and deaths of the reporter cells. These results indicate that lipid peroxidation and its aftereffects propagate from ferroptotic cells to surrounding cells, even when the surrounding cells are not exposed to FINs. Ferroptotic cells are not merely dying cells but also work as signal transmitters inducing a chain of further ferroptosis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Tohoku University Graduate School of Medicine, Department of Biochemistry, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943)
2 Tohoku University Graduate School of Medicine, Department of Biochemistry, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943); Tohoku University Graduate School of Medicine, Center for Regulatory Epigenome and Diseases, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943)
3 Tohoku University, Department of Molecular Oncology, Institute of Development, Aging and Cancer, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943)
4 Tohoku University Graduate School of Medicine, Department of Biochemistry, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943); Tohoku University Graduate School of Medicine, Department of Hematology and Rheumatology, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943); Emory University, Department of Medicine, Division of Rheumatology, Lowance Center for Human Immunology, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)
5 Tohoku University Graduate School of Medicine, Department of Biochemistry, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943); Tohoku University Graduate School of Medicine, Department of Pediatric Surgery, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943)
6 National Research Institute for Child Health and Development, Department of Human Genetics, Tokyo, Japan (GRID:grid.63906.3a) (ISNI:0000 0004 0377 2305)
7 Tohoku University Graduate School of Medicine, Department of Biochemistry, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943); Tohoku University Graduate School of Medicine, Department of Hematology and Rheumatology, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943)